Connection

Michael von Bergwelt-Baildon to Antineoplastic Agents

Back to Details
This is a "connection" page, showing publications Michael von Bergwelt-Baildon has written about Antineoplastic Agents.
Michael von Bergwelt-Baildon
Connection Strength
0.351
Antineoplastic Agents
  1. Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Eur J Cancer. 2020 11; 140:86-104.
    View in: PubMed
    Score: 0.068
  2. [Systemic Therapy of Metastatic Colorectal Cancer]. Zentralbl Chir. 2019 Jun; 144(3):252-258.
    View in: PubMed
    Score: 0.062
  3. Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer. Cancer Res. 2018 08 01; 78(15):4270-4281.
    View in: PubMed
    Score: 0.058
  4. The Intensive Care Medicine research agenda on critically ill oncology and hematology patients. Intensive Care Med. 2017 Sep; 43(9):1366-1382.
    View in: PubMed
    Score: 0.055
  5. Innovative Treatment Concepts for Cutaneous T-Cell Lymphoma Based on Microenvironment Modulation. Oncol Res Treat. 2017; 40(5):262-269.
    View in: PubMed
    Score: 0.054
  6. Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors. Immunotherapy. 2017 03; 9(5):423-433.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.